Who Is a Good Candidate for Ketamine Therapy? A Guide for Patients and Providers

Ketamine therapy offers new hope for patients with treatment-resistant depression, PTSD, OCD, and other conditions, but careful candidate selection is essential. Learn which factors determine eligibility, what contraindications to watch for, and why a thorough medical evaluation is the foundation of safe, effective treatment.

Ketamine therapy has emerged as an important treatment option for individuals with treatment-resistant depression and other mental health conditions that have not responded adequately to conventional care. However, not every patient is an appropriate candidate, making careful screening an essential part of the treatment process.

Whether you’re a healthcare provider considering a referral or a patient exploring your options, this guide explains the factors clinicians look at when determining if ketamine therapy is likely to be safe, appropriate, and beneficial.

 

Who is a good candidate for ketamine therapy?

 

Ketamine therapy is most often considered for individuals who continue to struggle despite conventional treatment. Ketamine treatment can help people living with severe depression, anxiety disorders, PTSD, OCD, bipolar depression, or alcohol use disorder who have not achieved adequate relief through psychotherapy, antidepressant medications, or other standard interventions. 

If you or your patient has experienced significant side effects from traditional psychiatric medications or have reached a plateau in your progress despite ongoing treatment, ketamine may be a highly effective treatment option for you. 

Medical suitability is also an important consideration. Candidates should be adults who are healthy enough to safely undergo treatment, and willing and able to participate in the recommended treatment protocol. This includes attending scheduled appointments and arranging transportation home following treatment sessions.

Ultimately, ketamine, when administered in a supervised clinical setting, has become an established second-line treatment option for a range of mental health conditions. Supported by a substantial body of clinical research and over two decades of medical use in mental health, it offers a valuable alternative for candidates who have not achieved adequate relief through conventional approaches. 

 

Who isn’t a good candidate for ketamine therapy?

 

While ketamine therapy can be highly effective for many patients, there are certain contraindications that make treatment inappropriate. Ketamine treatment is generally not recommended if you or your patient:

  • Have schizophrenia, a history of psychosis, or are currently experiencing psychotic symptoms
  • Are experiencing active mania
  • Have uncontrolled high blood pressure, serious cardiovascular disease, a history of aneurysm, or a history of brain bleed
  • Have uncontrolled thyroid disease
  • Engage in active substance misuse that would interfere with safe treatment
  • Are pregnant or trying to conceive

Before beginning treatment, every patient undergoes a comprehensive medical evaluation to ensure ketamine therapy is a safe and appropriate option.

 

Why determining suitable candidates for ketamine therapy matters

 

Finding out whether you or your patient is a good candidate for ketamine therapy is about much more than checking boxes on a list. A careful evaluation helps ensure that treatment is not just safe, but also that it’s likely to provide meaningful benefits. It also gives referring providers greater confidence that ketamine is an appropriate next step in a patient’s care.

At Keta Medical Center, our medical director takes the time to understand you or your patient’s symptoms, treatment history, medical conditions, and current medications. A comprehensive medical evaluation helps determine whether ketamine is the right treatment for each individual situation or whether another approach should be considered first. Throughout the evaluation process, we collaborate closely with referring providers to ensure treatment decisions are informed by a holistic understanding of the patient’s history and goals.

The evaluation also helps our team determine the most appropriate treatment pathway, including whether a patient meets diagnostic criteria for the insurance-covered nasal spray Spravato®

Proper candidate selection is the prerequisite for optimal outcomes. Patients who are appropriately matched with ketamine treatment are more likely to experience meaningful improvements in their symptoms and quality of life. At the same time, identifying contraindications early helps minimize unnecessary risks.

 

Talk to our doctors to determine if you or your patient is a fit

 

If you or your patient is living with depression, anxiety, PTSD, OCD, or alcohol use disorder and feel like you’ve exhausted traditional options, a consultation can help you understand whether ketamine therapy may be appropriate for you.

At Keta Medical Center, our clinical team will make a thorough assessment before  recommending treatment. We can also help you understand whether insurance may cover treatment and explain what to expect throughout the treatment process, from your first appointment through ongoing care. 

If you’re a provider, we value close collaboration — after all, you’re the one who knows your patient best. Our approach is that ketamine treatment is always one component of a broader care plan, not a replacement for the therapeutic relationships and ongoing support that are already in place.

We proudly serve patients throughout New York and New Jersey, making advanced, physician-supervised ketamine treatment accessible to individuals seeking relief and a better life. Whether you’re exploring treatment for yourself or referring a patient who has not responded to conventional therapies, our team is here to help guide the next steps.

Ready to learn whether ketamine therapy may be right for you or your patient? Schedule a free consultation today

FAQ’s

How many failed antidepressant trials are required before a patient qualifies for ketamine therapy?
For a patient to qualify for insurance-covered Spravato treatment, the diagnostic criteria for treatment-resistant depression have to be met. That means they need to have gone through at least two separate trials of antidepressant medication. To be treated with IV ketamine, patients don’t need to have tried antidepressants beforehand.
Can I refer a patient who is still on antidepressants or other psychiatric medications?

Yes. Patients taking antidepressants can typically undergo ketamine treatment safely under medical supervision, and many continue their antidepressant regimen throughout treatment. Other psychiatric medications should be reviewed on a case-by-case basis to assess potential interactions, safety considerations, and their impact on treatment response.

What psychiatric diagnoses are appropriate for a ketamine referral?

Ketamine therapy may be appropriate for patients living with treatment-resistant depression, anxiety disorders, PTSD, OCD, bipolar depression, or alcohol use disorder, particularly when conventional treatments have not provided adequate relief. Ultimately, candidacy is determined by the individual's symptoms, treatment history, overall health, and the presence or absence of any contraindications.

Does a patient need to have tried TMS or ECT before being eligible for ketamine?

No. Ketamine is often considered a second-line treatment option for patients who have not achieved adequate relief through psychotherapy, antidepressant medications, or other conventional approaches. Patients do not need to undergo transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) before being considered for ketamine treatment.

What medical conditions should I flag before referring a patient?

Providers should flag any history of psychosis, schizophrenia, or active mania; uncontrolled high blood pressure; serious cardiovascular disease; aneurysm or brain bleed; uncontrolled thyroid disease; active substance misuse; and pregnancy. These conditions require careful evaluation and most likely make ketamine treatment inappropriate or unsafe.

Disclaimer

This article is for informational purposes only and should not replace professional medical advice. We encourage you to discuss any treatment options with your doctor or mental health provider to fully understand the potential risks and benefits. If you are in immediate danger, please contact the National Suicide Prevention Lifeline at 988, dial 911, or visit your nearest emergency room.

Related Blog Posts

Ketamine therapy offers new hope for patients with treatment-resistant depression, PTSD, OCD, and other conditions, but careful candidate selection is essential. Learn which factors determine eligibility, what contraindications to watch for, and why a thorough medical evaluation is the foundation of safe, effective treatment.
The April 2026 executive order marks one of the most significant federal shifts in mental health policy in decades. Here's what it actually does, what it doesn't, and what it could mean for the future of psychedelic-assisted therapy.
Psilocybin therapy is moving closer to mainstream medicine, but the legal picture is more complicated than recent headlines suggest. We break down federal vs. state law, the impact of the 2026 executive order, and what patients can access right now.
;